The International Myeloma Foundation (IMF) Welcomes Visionary & Strategic Fundraiser Sylvia Dsouza as Vice President of Philanthropy Read more about The International Myeloma Foundation (IMF) Welcomes Visionary & Strategic Fundraiser Sylvia Dsouza as Vice President of Philanthropy Add new comment
IMF Honors Two Outstanding Researchers: Dr. María-Victoria Mateos and Dr. Thomas Martin Read more about IMF Honors Two Outstanding Researchers: Dr. María-Victoria Mateos and Dr. Thomas MartinAdd new comment
FDA Grants Accelerated Approval for ELREXFIO™ (elranatamab-bcmm) for Heavily Pre-treated Multiple Myeloma Patients Read more about FDA Grants Accelerated Approval for ELREXFIO™ (elranatamab-bcmm) for Heavily Pre-treated Multiple Myeloma PatientsAdd new comment
FDA Approves TALVEY™ (talquetamab-tgvs) for Heavily Pre-Treated Multiple Myeloma Read more about FDA Approves TALVEY™ (talquetamab-tgvs) for Heavily Pre-Treated Multiple MyelomaAdd new comment
2023 ASCO and EHA: Bispecifics, CAR T, and More! Read more about 2023 ASCO and EHA: Bispecifics, CAR T, and More! Add new comment
Myeloma Support Group Leader Jack Aiello and Global Finance & Strategy Leader Sanjay Singh Elected to IMF Board of Directors Read more about Myeloma Support Group Leader Jack Aiello and Global Finance & Strategy Leader Sanjay Singh Elected to IMF Board of Directors Add new comment
A Q&A with Newly Elected IMF Board Members, Support Group Leader Jack Aiello and Global Finance & Strategy Leader Sanjay Singh Read more about A Q&A with Newly Elected IMF Board Members, Support Group Leader Jack Aiello and Global Finance & Strategy Leader Sanjay SinghAdd new comment
LatentView Analytics and the International Myeloma Foundation Harness the Power of Data to Improve the Lives of Myeloma Patients Read more about LatentView Analytics and the International Myeloma Foundation Harness the Power of Data to Improve the Lives of Myeloma Patients Add new comment
Positive CHMP Opinions Received for Novel Bispecific Antibodies TALVEY® (talquetamab) and TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma Read more about Positive CHMP Opinions Received for Novel Bispecific Antibodies TALVEY® (talquetamab) and TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed and Refractory Multiple MyelomaAdd new comment
World-Renowned Scientist, S. Vincent Rajkumar, MD, Appointed as Chairman-Elect of the Board of Directors of the International Myeloma Foundation (IMF) Read more about World-Renowned Scientist, S. Vincent Rajkumar, MD, Appointed as Chairman-Elect of the Board of Directors of the International Myeloma Foundation (IMF) Add new comment
